KOS 2007: The Role of Donor-Lymphocyte Infusion and Other Post-Transplant Strategies After Allografting in Multiple Myeloma

Nikolaus Kröger

AUTHORS: N. Kröger¹, F. Ayuk¹, D. Atanackovic², A. Zander^1
1 Dept. of Stem Cell Transplantation, University Hospital Hamburg-Eppendorf, Germany
² Dept. of Oncology and Hematology, University Hospital Hamburg-Eppendorf, Germany

Donor-lymphocyte infusions (DLI) provide effective treatment for patients who experienced relapse after allogeneic stem cell transplantation. Meanwhile the graft-versus-myeloma effect of DLI is well established. Several attempts had been made in the last years to improve the efficacy of DLI after allogeneic stem cell transplantation for multiple myeloma.